In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Critical Therapeutics, Cornerstone merge in $64mm stock deal

Executive Summary

Publicly traded Critical Therapeutics (lung, inflammatory, and critical care diseases) and private start-up Cornerstone BioPharma have agreed to merge to form a company strong in treatments for respiratory disorders.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Reverse Acquisition
    • Payment Includes Stock

Related Companies

UsernamePublicRestriction

Register